Literature DB >> 30724020

Flexible piecewise linear model for investigating dose-response relationship in meta-analysis: Methodology, examples, and comparison.

Chang Xu1, Lehana Thabane2,3, Tongzu Liu4, Asm Borhan2,3, Xin Sun1.   

Abstract

OBJECTIVES: Dose-response meta-analysis (DRMA) is widely employed in establishing the potential dose-response relationship between continuous exposures and disease outcomes. However, there is no valid DRMA method readily for discrete exposures, especially when the possible dose-response trend not likely to be linear. We proposed a piecewise linear DRMA model as a solution to this issue.
METHODS: We illustrated the methodology of piecewise linear model in both one-stage DRMA approach and two-stage DRMA approach. The method by testing the equality of slopes of each piecewise was employed to judge if there is "piecewise effect" against a simple linear trend. We then used sleep (continuous exposure) and parity (discrete exposure) data as examples to illustrate how to apply the model in DRMA using the Stata code attached. We also empirically compared the slopes of piecewise linear model with simple linear as well as restricted cubic spline model.
RESULTS: Both one-stage and two-stage piecewise linear DRMA model fitted well in our examples, and the results were similar. Obvious "piecewise effects" were detected in both the two samples by the method we used. In our example, the new model showed a better fitting effect and practical, reliable results compared to the simple linear model, while similar results for to restricted cubic spline model.
CONCLUSION: Piecewise linear function is a valid and straightforward method for DRMA and can be used for discrete exposures, especially when the simple linear function is under fitted. It represents a superior model to linear model in DRMA and may be an alternative model to the nonlinear model.
© 2019 Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  discrete exposure; dose-response meta-analysis; piecewise linear function

Mesh:

Year:  2019        PMID: 30724020     DOI: 10.1111/jebm.12339

Source DB:  PubMed          Journal:  J Evid Based Med        ISSN: 1756-5391


  6 in total

Review 1.  An overview on the methodological and reporting quality of dose-response meta-analysis on cancer prevention.

Authors:  Chang Xu; Yu Liu; Chao Zhang; Joey S W Kwong; Jian-Guo Zhou; Long Ge; Jing-Yu Huang; Tong-Zu Liu
Journal:  J Cancer Res Clin Oncol       Date:  2019-03-13       Impact factor: 4.553

Review 2.  Association between maternal breastfeeding and risk of systemic neoplasms of offspring.

Authors:  Qin-Qin Gong; Dan-Dan Quan; Chong Guo; Chao Zhang; Zhi-Jun Zhang
Journal:  Ital J Pediatr       Date:  2022-06-16       Impact factor: 3.288

3.  Protocol registration or development may benefit the design, conduct and reporting of dose-response meta-analysis: empirical evidence from a literature survey.

Authors:  Chang Xu; Liang-Liang Cheng; Yu Liu; Peng-Li Jia; Ming-Yue Gao; Chao Zhang
Journal:  BMC Med Res Methodol       Date:  2019-04-11       Impact factor: 4.615

4.  Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs.

Authors:  Jie Chen; Kaibo Mei; Lixia Xie; Ping Yuan; Jianyong Ma; Peng Yu; Wengen Zhu; Chunhua Zheng; Xiao Liu
Journal:  Nutr J       Date:  2021-10-31       Impact factor: 3.271

5.  Relationship between serum growth differentiation factor 15, fibroblast growth factor-23 and risk of atrial fibrillation: A systematic review and meta-analysis.

Authors:  Ziqi Tan; Tiangang Song; Shanshan Huang; Menglu Liu; Jianyong Ma; Jing Zhang; Peng Yu; Xiao Liu
Journal:  Front Cardiovasc Med       Date:  2022-08-04

6.  Dose-response relationship among body mass index, abdominal adiposity and atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of 35 cohorts.

Authors:  Menglu Liu; Kaibo Mei; Lixia Xie; Jianyong Ma; Peng Yu; Siquan Niu; Ya Xu; Yujie Zhao; Xiao Liu
Journal:  PeerJ       Date:  2021-07-21       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.